Yubo International Biotech Ltd.
About Yubo International Biotech Ltd. Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the ...
Model output · Signal date 2026-11-04
Yubo International Biotech Ltd (YBGJ) Stock Forecast Nov. 4, 2026
Analysis updated on Nov. 4, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Rating · 90D
Unlock rating and forecasts
90-day forecast
Sign up free to reveal
30-day forecast
Total
Rank in coverage
of 4007 stocks scored
Rank correlation · 90D
-30.0%
Spearman, 358 dates
Market Cap
n/a
Summary
Yubo International Biotech Ltd (YBGJ) stock forecast summary
Our AI scores Yubo International Biotech Ltd every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Its market capitalization is not available, so no size classification is given.
For YBGJ, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -30.0%, measured on 358 forecast dates between 2022-08-17 and 2026-08-06 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -18.0%, measured on 400 forecast dates between 2022-08-17 and 2026-10-05. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +6.2%, buy ≥ +4.2%, sell < +2.2%, strong sell < +0.5% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, YBGJ included.
Price
YBGJ price chart and AI forecast
Cross-section · 2026-11-06
How YBGJ ranks among 4007 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals · 2026-06-30
Yubo International Biotech Ltd (YBGJ) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Electromedical & Electrotherapeutic Apparatus peers listed below that report each metric.
Valuation & Market
| Metric | YBGJ | Rank |
|---|---|---|
| EPS | $-0.01 | – |
Profitability & Margins
| Metric | YBGJ | Rank |
|---|---|---|
| Tax Rate | 0.0% | – |
Financial Health
| Metric | YBGJ | Rank |
|---|---|---|
| Current Ratio | 0.18x | 26/27 |
| Quick Ratio | 0.17x | 25/26 |
| Interest Coverage | 7298.4x | 1/27 |
| Working Capital | -$3M | 25/26 |
Cash Flow
| Metric | YBGJ | Rank |
|---|---|---|
| Operating Cash Flow | -$780K | 11/27 |
Operational Efficiency
| Metric | YBGJ | Rank |
|---|---|---|
| Receivables Turnover | 0.1x | 19/19 |
| Inventory Turnover | 0.2x | 25/25 |
| Fixed Assets Turnover | 0.7x | 19/19 |
| Days Sales Outstanding | 4079 days | 1/19 |
| Days Inventory | 2162 days | 1/25 |
| Payables Period | 113947 days | 1/23 |
| Cash Conversion Cycle | -107706 days | 18/18 |
Income Statement
| Metric | YBGJ | Rank |
|---|---|---|
| Total Revenue | $10K | 18/18 |
| Operating Income | -$1M | 10/27 |
| Net Income | -$920K | 9/19 |
| Cost of Goods Sold | $0.00M | 25/25 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $580K | |
| Cash & Short-term Investments | $10K | |
| Accounts Receivable | $140K | |
| Inventory | $20K | |
| Total Liabilities | $5M | |
| Short-term Debt | $2M |
Quarterly Financial Reports
YBGJ quarterly financials and insider trading
Industry Peers · Electromedical & Electrotherapeutic Apparatus
Yubo International Biotech Ltd (YBGJ) industry peers
Companies classified under the same SEC industry code as Yubo International Biotech Ltd (Electromedical & Electrotherapeutic Apparatus): 29 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| YBGJ Yubo International Biotech Ltd | N/A | |
| MDT Medtronic Plc | $134.10B | |
| LIVN Livanova Plc | $5.02B | |
| ITGR Integer Holdings Corp | $4.31B | |
| AXGN Axogen, Inc. | $2.91B | |
| TMDX Transmedics Group, Inc. | $2.39B | |
| CNMD Conmed Corp | $1.57B | |
| CBLL Ceribell, Inc. | $998M | |
| INMD Inmode Ltd. | $770M | |
| CV Capsovision, Inc | $310M | |
| ELMD Electromed, Inc. | $224M | |
| FOCL Edap Tms Sa | $159M | |
| STXS Stereotaxis, Inc. | $105M | |
| VANI Vivani Medical, Inc. | $95M | |
| ECOR Electrocore, Inc. | $79M | |
| OM Outset Medical, Inc. | $77M | |
| NRXS Neuraxis, Inc | $77M | |
| HYPR Hyperfine, Inc. | $73M | |
| POCI Precision Optics Corporation, Inc. | $54M | |
| POSC Positron Corp | $54M | |
| QTI Qt Imaging Holdings, Inc. | $30M | |
| ITOC Itonic Holdings Ltd | $12M | |
| IRIX Iridex Corp | $12M | |
| GTHP Guided Therapeutics Inc | $10M | |
| NDRA Endra Life Sciences Inc. | $8M | |
| ADMT Adm Tronics Unlimited, Inc. | $6M | |
| NUWE Nuwellis, Inc. | $2M | |
| ESMC Escalon Medical Corp | $1M | |
| NXL Nexalin Technology, Inc. | $1M |
Where YBGJ sits on the market map
Industrial Applications and Services · Electromedical & Electrotherapeutic Apparatus
News
Yubo International Biotech Ltd (YBGJ) stock news
Yubo International Biotech Ltd.
Yubo International Biotech Ltd. Annual cash flow by MarketWatch. View YBGJ net cash flow, operating cash flow, operating expenses and cash dividends.
Yubo International Biotech Ltd.
Yubo International Biotech Ltd. Annual stock financials by MarketWatch. View the latest YBGJ financial statements, income statements and financial ratios.
FAQ
Yubo International Biotech Ltd (YBGJ) stock forecast FAQ
What is the Yubo International Biotech Ltd (YBGJ) stock forecast?
Our AI scores Yubo International Biotech Ltd every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Yubo International Biotech Ltd stock predictions?
For YBGJ, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -30.0%, measured on 358 forecast dates between 2022-08-17 and 2026-08-06 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -18.0%, measured on 400 forecast dates between 2022-08-17 and 2026-10-05. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Yubo International Biotech Ltd forecasts updated?
Yubo International Biotech Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 4, 2026.
Which companies are Yubo International Biotech Ltd's industry peers?
29 issuers in our coverage, YBGJ included, share the SEC industry code Electromedical & Electrotherapeutic Apparatus. The largest are: Medtronic Plc (MDT), Livanova Plc (LIVN), Integer Holdings Corp (ITGR), Axogen, Inc. (AXGN), Transmedics Group, Inc. (TMDX), Conmed Corp (CNMD).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.